Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11771733 Lisinopril formulations

Patent 11771733 was granted and assigned to Silvergate Pharmaceuticals, Inc. on October, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Silvergate Pharmaceuticals, Inc.

Current Assignee

Silvergate Pharmaceuticals, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

David W. Miles

Gerold L. Mosher

Date of Patent

October 3, 2023

Patent Application Number

17507144

Date Filed

October 21, 2021

Patent Citations

US Patent 8927028 Pharmaceutical composition containing coated, floating particles

US Patent 9463183 Lisinopril formulations

US Patent 9616096 Lisinopril formulations

US Patent 9814751 Lisinopril formulations

US Patent 10039800 Lisinopril formulations

US Patent 10265370 Lisinopril formulations

US Patent 10406199 Lisinopril formulations

US Patent 11179434 Lisinopril formulations

...

Patent Citations Received

US Patent 12128083 Lisinopril formulations

0

Patent Primary Examiner

Sean M Basquill

CPC Code

...

Patent abstract

Provided herein are stable lisinopril oral liquid formulations. Also provided herein are methods of using lisinopril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and acute myocardial infarction.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11771733 Lisinopril formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.